Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
Zagazig University
Cancer Research UK
Carevive Systems, Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Memorial Sloan Kettering Cancer Center
University of Nebraska
Adela, Inc
Mayo Clinic
AC Camargo Cancer Center
Cancer Research UK
Case Comprehensive Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
IRCCS San Raffaele
Arab American University (Palestine)
Arcus Biosciences, Inc.
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
Washington University School of Medicine
Wuerzburg University Hospital
University of Alabama at Birmingham
Compugen Ltd
University of Alberta
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Karyopharm Therapeutics Inc
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Taproot Health
University of Modena and Reggio Emilia
Cedars-Sinai Medical Center
Centre Hospitalier Henri Duffaut - Avignon
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
Celgene
Novartis
Case Comprehensive Cancer Center
Incyte Corporation
Celgene
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
University of Wisconsin, Madison
LEO Pharma
Shenzhen BinDeBio Ltd.
Incyte Corporation